Harjeet Singh

5.1k total citations · 1 hit paper
57 papers, 3.4k citations indexed

About

Harjeet Singh is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Harjeet Singh has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 19 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Harjeet Singh's work include CAR-T cell therapy research (48 papers), Virus-based gene therapy research (11 papers) and Immune Cell Function and Interaction (9 papers). Harjeet Singh is often cited by papers focused on CAR-T cell therapy research (48 papers), Virus-based gene therapy research (11 papers) and Immune Cell Function and Interaction (9 papers). Harjeet Singh collaborates with scholars based in United States, Germany and Switzerland. Harjeet Singh's co-authors include Laurence J.N. Cooper, Richard E. Champlin, Helen Huls, Simon Olivares, Dean A. Lee, Partow Kebriaei, Sourindra N. Maiti, Tiejuan Mi, Lenka V. Hurton and Kirsten C. Switzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Harjeet Singh

51 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

2012 489 citations Cecele J. Denman, V. V. Senyukov et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harjeet Singh United States	29	2.6k	1.4k	1.2k	988	701	57	3.4k
Carolina Berger United States	28	3.0k 1.1×	1.5k 1.1×	1.2k 1.0×	1.1k 1.2×	782 1.1×	49	3.9k
Helen Huls United States	31	2.9k 1.1×	1.3k 0.9×	1.4k 1.1×	1.3k 1.3×	852 1.2×	55	3.7k
Simon Olivares United States	24	2.4k 0.9×	1.1k 0.8×	1.1k 0.9×	995 1.0×	686 1.0×	46	3.0k
Bambi Grilley United States	21	3.7k 1.4×	1.5k 1.1×	1.2k 1.0×	1.5k 1.5×	920 1.3×	69	4.4k
Karin Straathof United States	23	3.6k 1.3×	1.9k 1.4×	1.2k 1.0×	1.4k 1.4×	793 1.1×	38	4.6k
Gwenn Danet-Desnoyers United States	21	1.6k 0.6×	1.1k 0.8×	1.2k 1.0×	711 0.7×	408 0.6×	38	3.1k
Anja Feldmann Germany	29	1.9k 0.7×	935 0.7×	747 0.6×	439 0.4×	825 1.2×	97	2.6k
Sourindra N. Maiti United States	25	2.0k 0.7×	1.3k 1.0×	1.7k 1.3×	806 0.8×	471 0.7×	46	3.5k
Juan F. Vera United States	27	2.8k 1.0×	1.4k 1.0×	846 0.7×	1.0k 1.1×	749 1.1×	63	3.3k
Justin Eyquem United States	17	3.6k 1.4×	1.3k 0.9×	2.0k 1.6×	1.3k 1.3×	1.2k 1.8×	33	4.5k

Countries citing papers authored by Harjeet Singh

Since Specialization

Citations

This map shows the geographic impact of Harjeet Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harjeet Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harjeet Singh more than expected).

Fields of papers citing papers by Harjeet Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harjeet Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harjeet Singh. The network helps show where Harjeet Singh may publish in the future.

Co-authorship network of co-authors of Harjeet Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Harjeet Singh. A scholar is included among the top collaborators of Harjeet Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harjeet Singh. Harjeet Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Harjeet, et al.. (2025). Abstract 4361892: CKD and CKM Syndrome: Accelerated Progression to Arrhythmias in a National Cohort. Circulation. 152(Suppl_3).

Romain, Gabrielle, Paolo Strati, Ali Rezvan, et al.. (2022). Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. Journal of Clinical Investigation. 132(17). 36 indexed citations

Olivares, Simon, et al.. (2022). Gamma Delta T Cells for Acute Myeloid Leukemia. Blood. 140(Supplement 1). 12696–12696. 1 indexed citations

Tambaro, Francesco Paolo, Harjeet Singh, Michael Rytting, et al.. (2021). Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia. Leukemia. 35(11). 3282–3286. 123 indexed citations

Greenbaum, Uri, Fevzi Yalniz, Samer A. Srour, et al.. (2020). Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?. Biology of Blood and Marrow Transplantation. 26(10). 1759–1769. 7 indexed citations

Denning, Warren L., Sonny Ang, Simon Olivares, et al.. (2018). Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models. Oncogene. 37(27). 3686–3697. 45 indexed citations

Hurton, Lenka V., Harjeet Singh, Amer Najjar, et al.. (2016). Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells. Proceedings of the National Academy of Sciences. 113(48). E7788–E7797. 341 indexed citations

Kumaresan, Pappanaicken R., Nathaniel D. Albert, Harjeet Singh, et al.. (2016). Abstract A193: Bioengineered Dectin-1 CAR+ T cells to control invasive fungal infection. Cancer Immunology Research. 4(1_Supplement). A193–A193. 2 indexed citations

Thokala, Radhika, Simon Olivares, Tiejuan Mi, et al.. (2016). Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors. PLoS ONE. 11(8). e0159477–e0159477. 51 indexed citations

10.

Caruso, Hillary G., Lenka V. Hurton, Amer Najjar, et al.. (2015). Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. Cancer Research. 75(17). 3505–3518. 324 indexed citations

11.

Liadi, Ivan, Harjeet Singh, Gabrielle Romain, et al.. (2015). Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells. Cancer Immunology Research. 3(5). 473–482. 76 indexed citations

12.

Krishnamurthy, Janani, Brian Rabinovich, Tiejuan Mi, et al.. (2015). Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma. Clinical Cancer Research. 21(14). 3241–3251. 89 indexed citations

13.

Deniger, Drew C., Jianqiang Yu, M. Helen Huls, et al.. (2015). Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations. PLoS ONE. 10(6). e0128151–e0128151. 44 indexed citations

14.

Huls, M. Helen, Matthew J. Figliola, Margaret J. Dawson, et al.. (2013). Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood. Journal of Visualized Experiments. e50070–e50070. 43 indexed citations

15.

Switzer, Kirsten C., Tiejuan Mi, Sourindra Maiti, et al.. (2013). Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor. Molecular Therapy. 21(3). 638–647. 150 indexed citations

16.

Denman, Cecele J., V. V. Senyukov, Srinivas S. Somanchi, et al.. (2012). Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells. PLoS ONE. 7(1). e30264–e30264. 489 indexed citations breakdown →

17.

Singh, Harjeet, Matthew J. Figliola, Margaret J. Dawson, et al.. (2011). Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies. Cancer Research. 71(10). 3516–3527. 161 indexed citations

18.

Maiti, Sourindra N., Helen Huls, Harjeet Singh, et al.. (2011). The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Therapy. 18(9). 849–856. 89 indexed citations

19.

Kelly, Susan S., Harjeet Singh, Matthew J. Figliola, et al.. (2010). Adoptive Immunotherapy After Umbilical Cord Blood (UCB) Transplantation: Manufacturing And Analysis Of CD19-Specific UCB-Derived T-cells From Scant Numbers Of UCB Mononuclear Cells. Biology of Blood and Marrow Transplantation. 16(2). S182–S183. 1 indexed citations

20.

Singh, Harjeet, Lisa Marie Serrano, Simon Olivares, et al.. (2007). Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy. Cancer Research. 67(6). 2872–2880. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact